Formula for success for medical cannabis – reliable analysis combined with regulatory strategy and extensive service

Although medical cannabis is becoming increasingly established in the pharmaceutical sector in Germany, manufacturers, distributors and wholesalers are still faced with new challenges from the various local regulatory authorities, depending on the location of the company’s place of business.

Individual German state authorities deviate, sometimes massively, from the general view that medical cannabis is classified as a drug and categorize medical cannabis as an active pharmaceutical ingredient for an extemporaneous product.

“Therefore, please seek advice in good time – as early as possible – and develop a strategy concept together with TentaConsult. We will be happy to assist you in its

implementation, both in the regulatory and in the quality (management) area. The close and timely coordination with your local competent authority is as important to us as the pragmatic and forward-looking strategy of a safe and sustainable quality concept. We are experienced and flexible enough to consider the interests of start-ups as well as those of established companies.”, states Ralf Sibbing, Managing Director or TentaConsult Pharma & Med GmbH

Together with the laboratory of DSI-pharm / Quality Services International GmbH (a Tentamus

Company), which is already holding a narcotics license according to article 3 of German Narcotics Act (BtMG), TentaConsult is ready to support you in cannabis analysis and thus completing its services to such an extent that you can obtain all external services from one source.

TentaConsult currently supports numerous companies with consulting and implementation regarding: 

  • GMP conformity, GACP requirements
  • Analytics (including stability testing),
  • Release analysis including market releases,
  • Assumption of responsible roles (BtMV / GHV / QP)
  • EU import,
  • Storage / wholesale,
  • GDP guidelines,
  • Placing on the market in accordance with the BtMG
  • Marketability testing of your product ideas.
Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 5
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190

Ralf Sibbing
Managing Partner – TentaConsult Pharma & Med GmbH
E-Mail: info@tentaconsult.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.